ALX ONCOLOGY HOLDINGS INC

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

ALXO$1.29+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	September 30,	December 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$23,442	$17,567
Short-term investments	37,184	110,190
Prepaid expenses and other current assets	5,890	6,595
Total current assets	66,516	134,352
Property and equipment, net	1,351	2,905
Long-term investments	5,838	3,524
Other assets	9,018	6,994
Total assets	$82,723	$147,775
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$6,583	$4,497
Payable and accrued liabilities due to related party	—	149
Term loan, current	4,348	435
Accrued expenses and other current liabilities	16,791	13,419
Total current liabilities	27,722	18,500
Term loan, non-current	5,764	9,469
Other non-current liabilities	4,437	6,188
Total liabilities	37,923	34,157
Commitments and contingencies (Note 12)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 53,577,566 and 53,052,912 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	54	53
Additional paid-in capital	744,672	734,412
Accumulated other comprehensive income	43	275
Accumulated deficit	(699,969)	(621,122)
Total stockholders’ equity	44,800	113,618
Total liabilities and stockholders’ equity	$82,723	$147,775

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.